Circulating cytokine signatures as a soluble biomarker of immune checkpoint inhibitor therapy in non-small-cell lung cancer

Genes & Immunity, Published online: 14 December 2023; doi:10.1038/s41435-023-00236-5Circulating cytokine signatures as a soluble biomarker of immune checkpoint inhibitor therapy in non-small-cell lung cancer

https://www.nature.com/articles/s41435-023-00236-5

Source: Genes and Immunity - December 14, 2023 Category: Genetics & Stem Cells Authors: Feifei Wei Tetsuro Sasada Source Type: research

More News: Cancer | Cancer & Oncology | Genetics | Lung Cancer | Non-Small Cell Lung Cancer